Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2025-12-30 @ 10:42 AM
Study NCT ID:
NCT04710134
Status:
COMPLETED
Last Update Posted:
2024-01-25
First Post:
2021-01-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma
Sponsor:
McMaster University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-10
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-09
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-08
First Submit QC Date:
None
Study First Post Date:
2021-01-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-24
Last Update Post Date:
2024-01-25
Last Update Post Date Type:
ACTUAL